— Know what they know.
Not Investment Advice

GYRE NASDAQ

Gyre Therapeutics, Inc.
1W: -11.7% 1M: -20.1% 3M: -25.4% YTD: -9.2% 1Y: -45.8% 3Y: +79.1% 5Y: -89.4%
$6.06
-0.12 (-1.94%)
 
Weekly Expected Move ±9.4%
$5 $6 $7 $7 $8
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 31 · $587.8M mcap · 18M float · 0.546% daily turnover · Short 61% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
43.3 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 1.1%
Cost Advantage ★
59
Intangibles
38
Switching Cost
43
Network Effect
48
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. GYRE shows a Weak competitive edge (43.3/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 1.1% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$17
Avg Target
$17
High
Based on 2 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 1Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$17.00
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2025-10-10 Jefferies Roger Song Initiated $16 +123.8% $7.15
2025-08-26 H.C. Wainwright Initiated $18 +125.0% $8.00

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
4
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. GYRE receives an overall rating of C-. Strongest factors: D/E (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-07 C+ C-
2026-04-01 B- C+
2026-03-16 D+ B-
2026-03-12 B- D+
2026-01-26 C+ B-
2026-01-14 B- C+
2026-01-03 B B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

44 Grade D
Profitability
20
Balance Sheet
94
Earnings Quality
43
Growth
46
Value
33
Momentum
45
Safety
100
Cash Flow
50
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. GYRE scores highest in Safety (100/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
16.76
Safe Zone
Piotroski F-Score
6/9
Beneish M-Score
-2.57
Unlikely Manipulator
Ohlson O-Score
-8.59
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 83.1/100
Trend: Deteriorating
Earnings Quality
OCF/NI: -0.69x
Accruals: -7.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. GYRE scores 16.76, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. GYRE scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. GYRE's score of -2.57 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. GYRE's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. GYRE receives an estimated rating of AA- (score: 83.1/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-88.02x
PEG
0.41x
P/S
5.02x
P/B
5.46x
P/FCF
209.78x
P/OCF
147.41x
EV/EBITDA
229.39x
EV/Revenue
5.00x
EV/EBIT
1033.90x
EV/FCF
192.81x
Earnings Yield
-0.99%
FCF Yield
0.48%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. GYRE currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
-11.147
NI / EBT
×
Interest Burden
0.996
EBT / EBIT
×
EBIT Margin
0.005
EBIT / Rev
×
Asset Turnover
0.803
Rev / Assets
×
Equity Multiplier
1.722
Assets / Equity
=
ROE
-7.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. GYRE's ROE of -7.4% is driven by Asset Turnover (0.803), indicating efficient use of assets to generate revenue. A tax burden ratio of -11.15 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$6.06
Median 1Y
$2.01
5th Pctile
$0.28
95th Pctile
$14.42
Ann. Volatility
117.8%
25th–75th percentile 5th–95th percentile Median path Historical

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
200,000
+3999900.0% YoY
Revenue / Employee
$583
Rev: $116,588,000
Profit / Employee
$25
NI: $5,027,000
SGA / Employee
$430
Avg labor cost proxy
R&D / Employee
$68
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -1.1% -1.2% -1.5% -1.0% 19.0% 56.3% 1.2% 1.1% -6.5% 11.0% -7.0% -6.6% -6.4% -6.7% 50.9% 30.5% 17.5% 28.0% 5.9% -7.4% -7.42%
ROA -79.9% -89.5% -1.2% -80.3% 14.8% 43.9% 71.0% 67.0% -3.9% 6.5% -92.3% -87.1% -85.4% -88.3% 10.0% 6.0% 3.4% 5.5% 3.4% -4.3% -4.31%
ROIC 37.2% 41.6% 20.6% 18.8% 19.9% 10.3% -59.5% 51.7% 36.8% 94.9% 1.1% 1.1% 1.1% 1.2% 32.6% 20.6% 18.3% 24.2% 14.4% 1.1% 1.12%
ROCE -1.0% -1.1% -2.1% -1.4% 33.8% 91.7% 78.6% 76.8% 12.5% 31.7% 19.9% 21.4% 19.6% 10.8% 15.3% 9.9% 8.8% 12.0% 8.2% 0.4% 0.38%
Gross Margin -4.6% -4.0% -0.6% -0.5% 95.2% 95.2% 95.5% 96.3% 96.3% 95.4% 96.4% 96.9% 96.2% 95.8% 95.9% 95.7% 94.7% 95.3% 94.6% 94.55%
Operating Margin -17.6% -11.0% -8.3% -18.5% 15.8% 16.2% 26.7% 17.0% 39.8% -3.4% 29.7% 12.9% 16.6% 2.1% 10.3% 8.1% 22.7% 0.3% -41.5% -41.54%
Net Margin -17.6% -11.0% -8.3% 6.3% -11.4% -12.2% 9.0% 6.3% 12.4% -3.7% 27.7% 14.0% 4.4% -0.4% 12.2% 1.7% 11.8% -4.6% -38.3% -38.26%
EBITDA Margin -17.6% -10.9% -8.3% 10.1% -3.3% -4.0% 27.9% 18.0% 40.5% -18.0% 31.2% 13.9% 18.5% 4.1% 12.7% 10.5% 27.1% 2.2% -41.5% -41.54%
FCF Margin -14.5% -12.9% -11.5% -10.8% -12.1% -1.6% -56.6% -15.0% 4.1% 15.2% 15.3% 9.8% 2.0% -2.3% -6.6% -10.5% -1.6% 1.3% -0.8% 2.6% 2.59%
OCF Margin -14.4% -12.7% -11.4% -10.7% -11.5% -1.5% -56.6% -12.9% 5.5% 18.3% 22.8% 15.9% 7.4% 2.2% -3.6% -6.8% 0.9% 3.6% 0.9% 3.7% 3.69%
ROA 3Y Avg snapshot only -24.40%
ROIC Economic snapshot only 0.58%
Cash ROA snapshot only 2.60%
Cash ROIC snapshot only 7.92%
CROIC snapshot only 5.56%
NOPAT Margin snapshot only 0.52%
Pretax Margin snapshot only 0.48%
R&D / Revenue snapshot only 14.82%
SGA / Revenue snapshot only 78.21%
SBC / Revenue snapshot only 5.68%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -24.41 -20.72 -4.52 -9.54 140.27 13.52 9.89 4.69 -135.25 120.06 -21.17 -20.46 -14.48 -14.49 102.42 108.57 181.24 115.19 144.57 -101.27 -88.020
P/S Ratio 341.64 258.73 54.16 86.56 281.45 13.77 8.43 2.67 3.29 4.80 17.34 15.50 11.15 12.25 11.70 7.82 7.39 7.14 6.23 5.44 5.022
P/B Ratio 24.80 23.57 9.67 14.04 37.90 10.86 11.59 5.19 8.65 12.97 -124.32 -113.30 -78.63 -81.32 19.55 12.43 11.92 12.10 6.85 6.00 5.462
P/FCF -23.53 -20.13 -4.70 -7.98 -23.35 -8.60 -14.89 -17.85 80.80 31.63 113.28 158.02 559.12 -536.97 -178.48 -74.70 -454.46 567.94 -792.54 209.78 209.777
P/OCF 59.37 26.19 76.00 97.68 151.52 557.67 860.73 197.62 719.57 147.41 147.412
EV/EBITDA -23.44 -19.87 -4.03 -9.31 105.01 10.41 8.12 3.47 33.90 21.90 95.18 80.51 60.36 106.16 68.02 62.73 63.67 49.30 45.89 229.39 229.395
EV/Revenue 327.57 247.51 48.10 79.89 273.41 12.40 8.01 2.38 3.07 4.59 17.05 15.22 10.86 11.94 11.47 7.57 7.14 6.91 5.79 5.00 4.999
EV/EBIT -23.40 -19.82 -4.01 -9.25 107.98 10.56 8.22 3.52 37.93 22.89 100.69 85.37 64.07 120.85 74.72 73.06 78.13 58.18 55.38 1033.90 1033.897
EV/FCF -22.56 -19.25 -4.17 -7.37 -22.68 -7.75 -14.15 -15.86 75.41 30.22 111.37 155.10 544.25 -523.16 -174.86 -72.32 -439.36 549.36 -736.40 192.81 192.812
Earnings Yield -4.1% -4.8% -22.1% -10.5% 0.7% 7.4% 10.1% 21.3% -0.7% 0.8% -4.7% -4.9% -6.9% -6.9% 1.0% 0.9% 0.6% 0.9% 0.7% -1.0% -0.99%
FCF Yield -4.2% -5.0% -21.3% -12.5% -4.3% -11.6% -6.7% -5.6% 1.2% 3.2% 0.9% 0.6% 0.2% -0.2% -0.6% -1.3% -0.2% 0.2% -0.1% 0.5% 0.48%
PEG Ratio snapshot only 0.413
Price/Tangible Book snapshot only 6.285
EV/OCF snapshot only 135.491
EV/Gross Profit snapshot only 5.258
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 5.03 5.03 3.63 3.63 3.63 3.63 4.06 4.06 4.06 4.06 2.85 2.85 2.85 2.85 3.32 3.32 3.32 3.32 5.60 5.60 5.598
Quick Ratio 5.03 5.03 3.63 3.63 3.63 3.63 3.56 3.56 3.56 3.56 2.64 2.64 2.64 2.64 2.99 2.99 2.99 2.99 5.04 5.04 5.042
Debt/Equity 0.02 0.02 0.06 0.06 0.06 0.06 0.01 0.01 0.01 0.01 -0.03 -0.03 -0.03 -0.03 0.03 0.03 0.03 0.03 0.01 0.01 0.009
Net Debt/Equity -1.02 -1.02 -1.08 -1.08 -1.08 -1.08 -0.58 -0.58 -0.58 -0.58 -0.40 -0.40 -0.40 -0.40 -0.49 -0.49 -0.486
Debt/Assets 0.02 0.02 0.04 0.04 0.04 0.04 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.006
Debt/EBITDA -0.02 -0.02 -0.03 -0.04 0.17 0.06 0.01 0.01 0.06 0.03 0.02 0.02 0.02 0.03 0.09 0.13 0.14 0.11 0.06 0.37 0.368
Net Debt/EBITDA 1.01 0.90 0.51 0.78 -3.09 -1.15 -0.43 -0.43 -2.42 -1.02 -1.63 -1.51 -1.65 -2.80 -1.41 -2.06 -2.19 -1.67 -3.50 -20.18 -20.183
Interest Coverage -4205.63 121.11 326.07 68.44 68.02 12.63 32.15
Equity Multiplier 1.25 1.25 1.35 1.35 1.35 1.35 1.99 1.99 1.99 1.99 -7.36 -7.36 -7.36 -7.36 1.98 1.98 1.98 1.98 1.57 1.57 1.567
Cash Ratio snapshot only 2.867
Cash to Debt snapshot only 55.831
FCF to Debt snapshot only 3.232
Defensive Interval snapshot only 292.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.06 0.07 0.10 0.09 0.07 0.43 0.83 1.18 1.59 1.63 1.13 1.15 1.11 1.04 0.87 0.83 0.84 0.89 0.80 0.80 0.803
Inventory Turnover 1.18 1.29 1.62 1.55 0.89 0.86 0.80 0.76 0.73 0.72 0.79 0.91 0.66 0.70 0.697
Receivables Turnover 0.60 0.76 2.86 2.60 2.16 12.63 6.71 9.47 12.84 13.17 7.38 7.53 7.26 6.83 6.09 5.80 5.89 6.18 4.14 4.16 4.158
Payables Turnover 1.11 1.40 1.22 1.11 0.92 0.76 1.11 1.21 1.52 1.45 19.44 18.83 17.54 16.59 16.78 16.41 18.06 20.95 46.69 49.56 49.560
DSO 605 482 128 140 169 29 54 39 28 28 49 48 50 53 60 63 62 59 88 88 87.8 days
DIO 0 0 0 0 0 0 309 283 225 235 410 423 454 480 499 510 464 400 556 524 524.0 days
DPO 330 261 300 330 395 478 330 303 241 251 19 19 21 22 22 22 20 17 8 7 7.4 days
Cash Conversion Cycle 275 221 -173 -190 -225 -449 33 19 13 12 440 452 483 511 537 551 505 441 637 604 604.5 days
Fixed Asset Turnover snapshot only 4.733
Operating Cycle snapshot only 611.8 days
Cash Velocity snapshot only 2.233
Capital Intensity snapshot only 1.419
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -69.4% -63.4% -65.0% 10.2% 0.2% 3.7% 7.0% 11.4% 19.2% 2.5% 94.1% 40.1% -0.3% -8.5% -6.8% -13.0% -8.4% 2.1% 10.2% 16.3% 16.30%
Net Income -62.3% -69.8% -56.4% 19.0% 1.1% 1.4% 1.6% 1.8% -1.2% -86.1% -2.9% -2.9% -30.6% -20.3% 1.1% 1.1% 1.0% 1.1% -58.4% -1.9% -1.87%
EPS 7.3% -19.4% -10.1% 63.4% 1.1% 1.2% 1.3% 1.7% -1.2% -88.9% -2.5% -2.3% -20.2% -15.4% 1.1% 1.1% 1.0% 1.1% -58.7% -2.0% -1.97%
FCF -1.2% -1.2% -52.9% 3.4% 16.8% 41.8% 60.9% 82.9% 1.1% 1.3% 1.5% 1.9% -51.1% -1.1% -1.4% -1.9% -1.7% 1.6% 86.8% 1.3% 1.29%
EBITDA -62.5% -69.6% -56.0% 23.3% 1.2% 1.4% 1.7% 2.0% -29.7% -37.7% -64.7% -61.3% 98.1% -50.9% -12.3% -44.4% -42.9% 27.3% -17.5% -79.0% -79.00%
Op. Income -55.8% -64.6% -53.2% -7.2% 14.7% 58.2% 87.2% 1.1% 1.3% 1.8% -5.0% -7.5% -4.2% -3.6% 1.2% 1.2% 1.1% 1.2% -28.9% -1.0% -1.01%
OCF Growth snapshot only 1.63%
Asset Growth snapshot only 32.48%
Equity Growth snapshot only 67.46%
Debt Growth snapshot only -41.24%
Shares Change snapshot only -10.42%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.0% 1.8% 71.5% 83.8% 82.4% 75.6% 1.7% 1.7% 1.5% 1.4% 1.5% 1.6% 49.0% 25.9% 12.3% 12.33%
Revenue 5Y 66.2% 73.9% 79.1% 64.1% 58.0% 1.1% 1.2% 1.6% 1.8% 2.2% 43.8% 41.5% 41.5% 41.0% 80.9% 80.86%
EPS 3Y -38.7% -50.7% -60.4%
EPS 5Y
Net Income 3Y -27.9% -41.4% -53.5%
Net Income 5Y
EBITDA 3Y -7.3% -27.0% -36.6% -64.4% -64.40%
EBITDA 5Y
Gross Profit 3Y 2.9% 1.1% 1.1% 54.6% 26.6% 12.3% 12.28%
Gross Profit 5Y 1.2% 54.2% 56.8%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 33.9% 33.9% -23.6% -23.6% -23.6% -23.6% -4.9% -4.9% -4.9% -4.9% 7.1% 7.1% 7.1% 7.1% 31.1% 31.1% 31.1% 31.1% 25.2% 25.2% 25.15%
Assets 5Y 6.4% 6.4% 7.9% 7.9% 7.9% 7.9% 16.5% 16.5% 16.5% 16.5% -1.4% -1.4% -1.4% -1.4% 4.9% 4.9% 4.9% 4.9% 11.9% 11.9% 11.86%
Equity 3Y 35.2% 35.2% -30.0% -30.0% -30.0% -30.0% -14.6% -14.6% -14.6% -14.6% 15.5% 15.5% 15.5% 15.5% 35.6% 35.6% 35.60%
Book Value 3Y -2.0% -2.0% -49.3% -59.8% -59.7% -59.3% -51.0% -49.4% -45.8% -43.6% -22.1% -1.7% -1.9% -2.9% 15.5% 24.1% 24.15%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.30 0.34 0.33 0.22 0.14 0.59 0.55 0.45 0.43 0.60 0.71 0.73 0.68 0.78 0.84 0.72 0.63 0.75 0.87 0.81 0.811
Earnings Stability 0.87 0.87 0.92 0.84 0.00 0.01 0.04 0.10 0.16 0.21 0.00 0.00 0.00 0.01 0.12 0.11 0.07 0.07 0.18 0.17 0.170
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.25 0.00 0.00 0.30 0.31 0.00 0.14 0.83 0.80 0.42 0.421
Rev. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.92 0.20 0.20 0.20 0.20 0.20 0.50 0.20 0.20 0.50 0.20 0.20 0.20 0.20 0.20 0.50 0.20 0.200
Earnings Smoothness 0.00 0.18
ROE Trend -0.47 -0.55 -1.37 -0.66 1.13 1.74 2.61 2.33 0.31 0.28
Gross Margin Trend 0.27 -0.07 0.56 0.67 0.98 0.98 0.55 0.50 0.50 0.50 0.06 0.01 0.01 -0.00 -0.01 -0.01 -0.01 -0.011
FCF Margin Trend -3.63 -3.76 5.92 6.52 11.46 13.33 7.38 6.20 5.60 6.03 0.70 0.14 -0.08 -0.05 -0.05 -0.05 0.03 0.029
Sustainable Growth Rate 19.0% -20.5% 11.5% 4.8% 11.0% 50.9% 30.5% 17.5% 28.0% 5.9%
Internal Growth Rate 17.3% 7.4% 3.0% 7.0% 11.1% 6.4% 3.6% 5.8% 3.6%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.03 1.02 0.95 1.18 -5.73 -1.49 -0.66 -0.23 -2.28 4.58 -0.28 -0.21 -0.10 -0.03 -0.32 -0.94 0.21 0.58 0.20 -0.69 -0.687
FCF/OCF 1.01 1.01 1.01 1.01 1.05 1.05 1.00 1.16 0.73 0.83 0.67 0.62 0.27 -1.04 1.82 1.54 -1.89 0.35 -0.91 0.70 0.703
FCF/Net Income snapshot only -0.483
OCF/EBITDA snapshot only 1.693
CapEx/Revenue 10.5% 12.7% 11.4% 12.6% 55.4% 7.9% 0.0% 2.1% 1.5% 3.2% 7.5% 6.1% 5.4% 4.5% 3.0% 3.7% 2.5% 2.4% 1.7% 1.1% 1.10%
CapEx/Depreciation snapshot only 0.647
Accruals Ratio 0.02 0.02 -0.06 0.15 0.99 1.09 1.18 0.82 -0.13 -0.23 -1.18 -1.05 -0.94 -0.91 0.13 0.12 0.03 0.02 0.03 -0.07 -0.073
Sloan Accruals snapshot only 0.253
Cash Flow Adequacy snapshot only 3.364
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 10.1% 9.1% 20.4% 12.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.74 $0.71 $0.64 $0.64 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 1.4% 90.3% 95.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 9.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 1.4% 90.3% 95.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Div. Increase Streak 0 0 0 0
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -2.6% -2.8% -12.5% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% 0.0% 0.0% 0.0% -0.0% -0.1% -0.1% -0.1% -3.2% -3.1% -3.3% -3.7% -3.67%
Total Shareholder Return -2.6% -2.8% -12.5% -0.0% -0.0% 10.1% 9.1% 20.4% 12.2% 0.0% 0.0% 0.0% -0.0% -0.1% -0.1% -0.1% -3.2% -3.1% -3.3% -3.7% -3.67%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.02 0.94 0.92 0.84 -0.27 0.21 1.21 1.24 1.22 1.14 0.52 0.47 0.36 0.44 0.35 -11.15 -11.147
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.05 0.78 0.93 0.95 1.00 1.11 0.96 -4.01 -3.43 -3.73 -7.50 1.43 1.47 1.24 1.20 1.18 1.00 0.996
EBIT Margin -14.00 -12.49 -11.98 -8.63 2.53 1.17 0.98 0.67 0.08 0.20 0.17 0.18 0.17 0.10 0.15 0.10 0.09 0.12 0.10 0.00 0.005
Asset Turnover 0.06 0.07 0.10 0.09 0.07 0.43 0.83 1.18 1.59 1.63 1.13 1.15 1.11 1.04 0.87 0.83 0.84 0.89 0.80 0.80 0.803
Equity Multiplier 1.34 1.34 1.28 1.28 1.28 1.28 1.68 1.68 1.68 1.68 7.54 7.54 7.54 7.54 5.09 5.09 5.09 5.09 1.72 1.72 1.722
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-2.47 $-2.76 $-2.80 $-0.96 $0.18 $0.54 $0.78 $0.67 $-0.04 $0.06 $-1.21 $-0.85 $-0.82 $-0.87 $0.12 $0.07 $0.04 $0.06 $0.05 $-0.07 $-0.07
Book Value/Share $2.43 $2.42 $1.31 $0.65 $0.65 $0.67 $0.67 $0.61 $0.61 $0.56 $-0.21 $-0.15 $-0.15 $-0.15 $0.62 $0.62 $0.62 $0.62 $1.03 $1.16 $1.50
Tangible Book/Share $2.43 $2.42 $1.31 $0.65 $0.65 $0.67 $0.64 $0.58 $0.58 $0.53 $-0.23 $-0.17 $-0.17 $-0.17 $0.60 $0.60 $0.60 $0.60 $0.98 $1.11 $1.11
Revenue/Share $0.18 $0.22 $0.23 $0.11 $0.09 $0.53 $0.92 $1.18 $1.60 $1.50 $1.48 $1.13 $1.07 $1.02 $1.03 $0.99 $1.00 $1.04 $1.13 $1.28 $1.28
FCF/Share $-2.56 $-2.84 $-2.69 $-1.15 $-1.06 $-0.85 $-0.52 $-0.18 $0.06 $0.23 $0.23 $0.11 $0.02 $-0.02 $-0.07 $-0.10 $-0.02 $0.01 $-0.01 $0.03 $0.03
OCF/Share $-2.54 $-2.81 $-2.67 $-1.14 $-1.01 $-0.81 $-0.52 $-0.15 $0.09 $0.27 $0.34 $0.18 $0.08 $0.02 $-0.04 $-0.07 $0.01 $0.04 $0.01 $0.05 $0.05
Cash/Share $2.53 $2.53 $1.49 $0.74 $0.74 $0.77 $0.40 $0.36 $0.36 $0.33 $0.44 $0.33 $0.32 $0.33 $0.26 $0.26 $0.26 $0.26 $0.51 $0.57 $0.41
EBITDA/Share $-2.46 $-2.75 $-2.79 $-0.91 $0.23 $0.63 $0.91 $0.81 $0.14 $0.31 $0.27 $0.21 $0.19 $0.12 $0.17 $0.12 $0.11 $0.15 $0.14 $0.03 $0.03
Debt/Share $0.05 $0.05 $0.08 $0.04 $0.04 $0.04 $0.01 $0.01 $0.01 $0.01 $0.01 $0.00 $0.00 $0.00 $0.02 $0.02 $0.02 $0.02 $0.01 $0.01 $0.01
Net Debt/Share $-2.48 $-2.48 $-1.42 $-0.71 $-0.71 $-0.73 $-0.39 $-0.35 $-0.35 $-0.32 $-0.43 $-0.32 $-0.32 $-0.32 $-0.25 $-0.25 $-0.24 $-0.24 $-0.50 $-0.56 $-0.56
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 16.763
Altman Z-Prime snapshot only 30.030
Piotroski F-Score 2 1 2 2 3 4 6 6 5 7 5 5 4 3 5 5 6 5 4 6 6
Beneish M-Score 1.29 2.59 -2.14 -2.77 13.01 20.05 35.90 12.14 -6.91 -6.36 -5.86 -5.76 -1.21 -1.13 -1.74 -1.78 -2.10 -2.57 -2.569
Ohlson O-Score snapshot only -8.589
ROIC (Greenblatt) snapshot only 0.52%
Net-Net WC snapshot only $0.86
EVA snapshot only $-4845758.87
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA-
Credit Score 74.02 73.71 55.23 61.83 89.64 89.90 90.46 90.10 94.90 96.90 20.00 20.00 20.00 20.00 87.96 87.80 90.30 94.08 91.00 83.14 83.140
Credit Grade snapshot only 4
Credit Trend snapshot only -4.656
Implied Spread (bps) snapshot only 100.000
Industry Credit Rank snapshot only 86
Sector Credit Rank snapshot only 78

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms